FzioMed aims for year-end U.S. approval
After nearly eight years of tangling with the Food and Drug Administration, San Luis Obipso-based FzioMed said it might receive approval to sell its products in the U.S. by year’s end.
NEXT ARTICLE →
Eminent domain suits clear way for Ventura County brine line
← PREVIOUS ARTICLE
Procore to build out South Coast operations with $15M Bessemer raise